Company profile · Onderzoeks- & kennisinstelling
Next Generation ImmunoDermatology
- Biotechnology
- Onderzoeks- & kennisinstelling
- Leiden
- Biotechnology · Leiden
- Employees
- 11–50
- Founded
- 2023
- Province
- Zuid-Holland
- Country
- Netherlands
About Next Generation ImmunoDermatology
Next Generation ImmunoDermatology, NGID for short, exists for one reason: to advance and improve dermatology treatments across six inflammatory skin conditions. NGID is a research consortium consisting of doctors and researchers from all university medical centers in the Netherlands. They join forces with technologists and data scientists, patients, students, and industrial partners. Together we gain new insights into skin diseases and we can start developing personalized treatment.
Keywords
- Communicatie
- Dermatologie
- Imaging
- Multi-Omics
- Organoids
- Wetenschap
Address
Headquarters
LeidenZuid-Holland, Netherlands
Similar companies
Companies with a similar profile, Zuid-Holland first.
Nextigen
Computer Software · Den Haag
2–10 employeesView profile
NGNG Investments
Investment Management · Den Haag
2–10 employeesView profile
Immunetune
Biotechnology · Leiden
2–10 employeesView profile
Nimvec Therapeutics
Biotechnology · Leiden
2–10 employeesView profile
MIDA Biotech B.V.
Biotechnology · Leiden
2–10 employeesView profile
InnoGI Technologies
Research · Delft
11–50 employeesView profile